Report
MarketLine Department
EUR 313.50 For Business Accounts Only

Nanocarrier Co., Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances And Investments

Summary

Marketline's Nanocarrier Co., Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Nanocarrier Co., Ltd. since January2007.

Marketline's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

Key Highlights

This report includes Nanocarrier Co., Ltd.'s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.

The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by Nanocarrier Co., Ltd.. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.

Scope


- Provides intelligence on Nanocarrier Co., Ltd.'s M&A, strategic partnerships and alliances, capital raising and private equity transactions.
- Detailed reports of various financial transactions undertaken by Nanocarrier Co., Ltd. and its subsidiaries since 2007.
- Information about key financial and legal advisors for Nanocarrier Co., Ltd.'s financial deals transactions.
- Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.

Reasons To Buy


- Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.
- Form an independent opinion about Nanocarrier Co., Ltd.’s growth strategies through the organic and inorganic activities undertaken since 2007.
- Track your competitors’ business structure and growth strategies.
Underlyings
CanBas Co. Ltd.

Canbas Co Ltd. CanBas Co., Ltd. is engaged in research and development of anticancer drugs which have little influence to the normal cells. In the general medicinal products development process, the Company is engaged in the exploration of compounds in accordance with the medicinal products subjects; the improvement of the compounds; the verification of the compounds on the animals; the application of investigational new drug (IND), as well as the initial stage of clinical investigation which tests the compounds on humans. The Company's developing items include CBP501, CBS9106 and others.

DNA Chip Research Inc.

DNA Chip Research is engaged in the life science development and research businesses. The Contract Research segment is engaged in the provision of contract analysis such as gene expression analysis service, miRNA expression analysis service, genome structural analysis service, C3 check service and digital PCR contract analysis service for universities, government research institutions, pharmaceutical companies, food companies, cosmetic companies and biotech companies. The Diagnosis segment is engaged in the provision of diagnostic such as immunity age, EGFR-NGS check, and rheumatism check 3 etc. for medical institutions and health-related companies by utilizing RNA checking technology.

Sumitomo Dainippon Pharma Co. Ltd.

Sumitomo Dainippon Pharma is engaged in the manufacture, sale/purchase, and import/export of pharmaceuticals, food additives, veterinary products, diagnostic agents and research materials. Pharmaceutical segment manufactures and sells medical and general pharmaceuticals including hypertension and angina drugs, digestive tract function prokinetic agents, peripheral circulation stimulant, and carbapenem antibiotics. Other business segment manufactures, purchases and sale of veterinary medicines, food additives, industrial chemicals, extracts, diagnostic drugs and materials for research and inspection; purchases and sells feed and feed additives.

Provider
MarketLine
MarketLine

MarketLine, a world-leading provider of commercial intelligence, has over 400 experienced analysts, consultants, and researchers with regional and sector expertise in market sizing, competitor tracking, socio and macro economics, and business drivers.

 For more than 15 years MarketLine has supported the research needs of investment banks, corporations, professional services firms, and academia with a unique mix of company, industry, country, city and financial data for every major industry and marketplace.

 MarketLine’ holistic business intelligence report collection includes:

 Industry Intelligence

‒ Industry Profiles

‒ Market Forecasts

‒ Porter’s Five Forces Analysis

 Company Intelligence

‒ Company Profiles

‒ SWOT Analysis

‒ Financial Deals

 Country and City Intelligence

‒ Country and City Profiles

‒ PEST/PESTLE Analysis

‒ Socio and macro-economic indicators

Analysts
MarketLine Department

Other Reports on these Companies
Other Reports from MarketLine

ResearchPool Subscriptions

Get the most out of your insights

Get in touch